Anti-CD3 antibody [KT3] (ab33429)
- Datasheet
- References (3)
- Protocols
Overview
-
Product name
Anti-CD3 antibody [KT3]
See all CD3 primary antibodies -
Description
Rat monoclonal [KT3] to CD3 -
Host species
Rat -
Tested applications
Suitable for: ICC/IF, Flow Cyt, IHC-Frmore details
Unsuitable for: IHC-P -
Species reactivity
Reacts with: Mouse -
Immunogen
Tissue/ cell preparation mature T cells (Mouse)
-
General notes
ab33429 may be used to trigger proliferation and cytotoxicity of CD3 positive cells.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. -
Storage buffer
pH: 7.40
Preservative: 0.09% Sodium azide
Constituent: PBS -
Concentration information loading... -
Purity
Protein G purified -
Purification notes
Purified from tissue culture supernatant. -
Primary antibody notes
ab33429 may be used to trigger proliferation and cytotoxicity of CD3 positive cells. -
Clonality
Monoclonal -
Clone number
KT3 -
Myeloma
NS0 -
Isotype
IgG2a -
Research areas
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab33429 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| ICC/IF | Use at an assay dependent concentration. | |
| Flow Cyt | 1/100. ab18450 - Rat monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
|
|
| IHC-Fr | Use at an assay dependent concentration. |
Application notes
Is unsuitable for IHC-P.
Target
-
Function
The CD3 complex mediates signal transduction. -
Involvement in disease
Defects in CD3D are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)/B(+)/NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. -
Sequence similarities
Contains 1 ITAM domain. -
Cellular localization
Membrane. - Information by UniProt
-
Database links
- Entrez Gene: 12500 Mouse
- Entrez Gene: 12501 Mouse
- Entrez Gene: 12502 Mouse
- Entrez Gene: 12503 Mouse
- SwissProt: P04235 Mouse
- SwissProt: P11942 Mouse
- SwissProt: P22646 Mouse
- SwissProt: P24161 Mouse
see all -
Alternative names
- 4930549J05Rik antibody
- A430104F18Rik antibody
- AW552088 antibody
see all
Images
-
![Immunohistochemistry (Frozen sections) - Anti-CD3 antibody [KT3] (ab33429)](https://www.abcam.com/ps/products/33/ab33429/Images/ab33429-46788-anti-cd3-antibody-kt3-immunohistochemistry.jpg)
Immunohistochemistry (Frozen sections) - Anti-CD3 antibody [KT3] (ab33429)Image courtesy of an anonymous Abreviewab33429 staining CD3 in mouse spleen tissue by Immunohistochemistry (frozen sections). Tissue was fixed with acetone and then blocked with 5% serum for 1 hour at 25°C followed by incubation with the primary antibody at a 1/250 dilution for 12 hours at 4°C. A goat anti-rabbit IgG conjugated to Alexa Fluor®488 was used as secondary antibody at a 1/250 dilution.
Protocols
Datasheets and documents
References
This product has been referenced in:
- Viitala M et al. Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors. Clin Cancer Res N/A:N/A (2019). Read more (PubMed: 30755440) »
- Chung WY et al. An ex vivo porcine spleen perfusion as a model of bacterial sepsis. ALTEX 36:29-38 (2019). Read more (PubMed: 30076761) »
